PHARMACORP RX INC (PCRX.CA) Stock Cash Flow
Canada - TSX Venture Exchange - TSX-V:PCRX - CA71714X1050 - Common Stock
0.415 CAD
-0.01 (-1.19%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 182.70K | -1.05M | -470.40K | -517.10K | -25.80K | |||
| Depreciation Amortization | 790.00K | 289.90K | N/A | N/A | N/A | |||
| Income Taxes - Deferred | -242.20K | -137.60K | N/A | N/A | N/A | |||
| Change In Working Capital | 1.06M | 708.10K | -49.00K | 10.60K | 26.30K | |||
| Other non cash items | -182.00K | 315.60K | 0.00 | 386.30K | 0.00 | |||
| OPERATING CASH FLOW | 1.61M | 125.00K | -519.50K | -120.20K | 500.00 | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -68.30K | -6.90K | N/A | N/A | N/A | |||
| Other Investing Activity | N/A | -16.86M | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -26.19M | -16.86M | N/A | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 2.95M | -107.10K | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 27.49M | 27.80K | 2.00M | 1.00M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -126.50K | -20.50K | |||
| FINANCING CASH FLOW | 2.93M | 27.38M | 27.80K | 1.87M | 979.50K | |||
| CHANGE IN CASH | -21.65M | 10.64M | -491.60K | 1.75M | 980.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 1.61M | 125.00K | -519.50K | -120.20K | 500.00 | |||
| Capital Expenditure | -68.30K | -6.90K | N/A | N/A | N/A | |||
| FREE CASH FLOW | 1.54M | 118.10K | -519.50K | -120.20K | 500.00 | |||
All data in CAD